We are live on
!
Find out more
Vir Biotechnology
215 hedge funds and large institutions have $783M invested in Vir Biotechnology in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more call options, than puts
Call options by funds: $2.65M | Put options by funds: $1.92M
36% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 25
3% more funds holding
Funds holding: 209 → 215 (+6)
4% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 72
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.15% less ownership
Funds ownership: 65.83% → 64.67% (-1.2%)
13% less capital invested
Capital invested by funds: $901M → $783M (-$118M)
Holders
215
Holders Change
+6
Holders Change %
+2.87%
% of All Funds
3.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
34
Increased
75
Reduced
72
Closed
25
Calls
$2.65M
Puts
$1.92M
Net Calls
+$732K
Net Calls Change
+$390K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$16.1M |
| 2 |
JP Morgan Chase
New York
|
+$7.6M |
| 3 |
Millennium Management
New York
|
+$5.82M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.54M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$18.9M |
| 3 |
Citigroup
New York
|
-$9.97M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$4.6M |
| 5 |
Barclays
London,
United Kingdom
|
-$4.52M |
